AstraZeneca
Executive Summary
Filing for the thymidylate synthase inhibitor ZD-9331 is anticipated for the second quarter of 2003. "The Pink Sheet" incorrectly referred to the compound as ZD-9333 (1"The Pink Sheet" Jan. 1, p. 22)
Filing for the thymidylate synthase inhibitor ZD-9331 is anticipated for the second quarter of 2003. "The Pink Sheet" incorrectly referred to the compound as ZD-9333 (1 ). |